ArticlePDF Available

The Impress of Low Level Lasers in the Treatment of Patients with in Virus COVID-19 (SARS-Cov-2)

The Impress of Low Level Lasers in the
Treatment of Patients with in Virus COVID-19
Ehsan Kamani
Keywords: Low-level laser therapy; Covid19; laserblue;
laserred; Virus; SARS-CoV-2, Corona.
Correspondence Author: University of Medical Sciences, Arak, Iran,
British Medical Laser Association (BMLA).
Year 2021
Global Journal of Medical Research Volume XXI Issue II Version I
21 Global Journals
Introduction One under laser blood irradiation, anti-
inflammatory effects were observed that improved the
immunologic activity of the blood.
A diminishing tendency of aggregation of
thrombocytes and an improved deformability of
erythrocytes result in an improved oxygen supply and
with that to a decrease of partial carbon dioxid pressure,
which is particularly relevant to wound healing.
Furthermore, the activation of phagocytic
activity of macrophages was proved in conjunction with
structural modifications. A positive effect on the
proliferation of lymphocytes and B-and T-cell-
subpopulations could be verified too [7]. According to
all studies, low-level laser, whether Therapy or
intravenous, can cause the following factors for the
recovery of patients with Covid 19 virus:
1. Reduce inflammation
2. Lymphocyte proliferation
3. Increase in nitric oxide
4. Increase vitamin D.
5. Increase oxygen
6. Improve the activity of red blood cells
Ethical Considerations
Not applicable.
Conflict of Interests
The authors declare no conflict of interest.
References Références Referencias
1. H. Li, S.-M. Liu, X.-H. Yu, et al. Coronavirus disease
2019 (COVID-19): current status and future
perspectives Int J Antimicrob Agents (2020),
p. 105951
2. Enwemekaa CS, Bumahab VV, Masson-Meyersc
DS.Light as a potential treatment for pandemic
coronavirus infections: a perspective.J Photochem
Photobiol B 2020; 111891. doi: 10.1164/ajrccm-
3. Mokmeli S, Vetrici M. Low level laser therapy as a
modality to attenuate cytokine storm at multiple
levels, enhance recovery, and reduce the use of
ventilators in COVID-19. Can J Respir Ther 2020;
56:2531. doi: 10.29390/cjrt-2020-015.
Early View
oronavirus disease 2019 (COVID-19) originated in
the city of Wuhan, Hubei Province, Central China.
COVID-19 is caused by a novel coronavirus,
named severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). At present, the newly identified SARS-
CoV-2 has caused a large number of deaths with
Millions person of confirmed cases worldwide, posing a
serious threat to public health. However, there are no
clinically approved vaccines or specific therapeutic
drugs available for COVID-19(1). The evidence shows
that blue 450 nm light is antimicrobial against numerous
bacteria, and that it accounts for Niels Ryberg Finsen's
Nobel-winning treatment of tuberculosis. Further
evidence shows that blue light inactivates several
viruses, including the common flu coronavirus, and that
in experimental animals, red and near infrared light
reduce respiratory disorders, similar to those
complications associated with coronavirus infection.
Moreover, in patients, red light has been shown to
alleviate chronic obstructive lung disease and bronchial
asthma(2). LLLT can be added to the conventional
treatment in COVID-19 at different stages of the disease.
Because of its anti-inflammatory effect, and ability to
shorten recovery times, LLLT can reduce the need of
ventilators in the healing process. Clinical trials are
necessary to objectively evaluate the effect of LLLT on
COVID-19 treatment and recovery(3). Blue laser light of
different wavelengths has been reported to have positive
effects on our immune system. in covid19 with The goal
is to reduce inflammation of the lungs and increase the
amount of nitric oxygen that will increase the body's
immunity and improve oxygen delivery to the blood and
tissues(4.5) The coronavirus has been shown to bind to
the cell via the angiotensin-converting enzyme receptor,
which is highly expressed in lung and heart cells. if
vitamin D levels in the body are balanced, acute cases
of coronary heart attack will not occur can balance
vitamin D in the body with yellow laser light, And largely
prevented the virus from invading the heart and
lungs(6). Effects and mode of operation of intravenous
Low-Level-Laser-Therapy of the blood.
4. Kamani, E., & Razaghi, M. (2020). Application of
Laser Blue Light With a Wavelength of 405 nm in the
Treatment of Patients with the Virus COVID-
19. Journal of Lasers in Medical Sciences, 11(4),
5. Razzaghi MD, Kamani E. Role low-power blue laser
with a wavelength of 405 nm in increasing the level
of nitric oxide in increasing the resistance of cells to
the virus (COVID-19) and its effect on virus (COVID-
19) mortality in vitro. OSP J Case Rep. 2020;
2(3): 1-3.
6. Kamani E. (2020) Effect of Low Level Yellow Laser
Light 589nm on Virus Prevention Corona Virus
(COVID-19). OSP J Case Rep 2. JCR-2-112.
7. Sirous Momenzadeh, Mohammadzaki Abbasi,
Asghar Ebadifar, Mohammadreza Aryani, Jafar
Bayrami, et al. (2015) The Intravenous Laser Blood
Irradiation in Chronic Pain and Fibromyalgia J
Lasers Med Sci 6: 6-9.
The Impress of Low Level Lasers in the Treatment of Patients with in Virus COVID-19 (SARS-Cov-2)
Year 2021
Global Journal of Medical Research Volume XXI Issue II Version I
21 Global Journals
Early View
ResearchGate has not been able to resolve any citations for this publication.
Full-text available
In today's world, the spread of coronavirus has disrupted the lives of society as a whole, and the goal of all research groups is to discover a cure for this emerging virus.Now, based on the studies we have done in this article, we have examined a research title that requires extensive experiments in this field so that we can achieve effective therapeutic results with this type of laser.
Full-text available
Abstract: Today, the coronavirus has become widespread worldwide and has become one of the most important research and therapeutic issues in global health. According to previous studies, vitamin D has an effect on prevention of corona virus in this article; I used this technique with low power laser and acupuncture.
Full-text available
Intravenous laser blood irradiation was first introduced into therapy by the Soviet scientists EN.Meschalkin and VS.Sergiewski in 1981. Originally this method was developed for the treatment of cardiovascular diseases. Improvement of rheologic properties of the blood as well as improvement of microcirculation and reduction of the area of infarction has been proved. Further, reduction of dysrhythmia and sudden cardiac death was achieved. At first, only the Helium-Neon laser (632.8 nm) was used in this therapy. For that, a power of 1-3mW and a period of exposure of 20-60 minutes were applied. The treatments were carried out once or twice a day up to ten appointments in all1. In the years after, many, and for the most part Russian studies showed that helium-neon laser had various effects on many organs and on the hematologic and immunologic system. The studies were published mainly in Russian which were little known in the West because of decades of political separation, and were regarded with disapproval. Besides clinical research and application for patients, the cell biological basis was developed by the Estonian cell biologist Tiina Karuat the same time. An abstract is to be found in her work “The Science of Low-Power Laser-Therapy” Keywords laser; pain; irradiation
Application of Laser Blue Light With a Wavelength of 405 nm in the Treatment of Patients with the Virus COVID-19
  • E Kamani
  • M Razaghi
Kamani, E., & Razaghi, M. (2020). Application of Laser Blue Light With a Wavelength of 405 nm in the Treatment of Patients with the Virus COVID-19. Journal of Lasers in Medical Sciences, 11(4), 361-362.